Hanson Kristopher 4
4 · PhaseBio Pharmaceuticals Inc · Filed Feb 28, 2022
Insider Transaction Report
Form 4
Hanson Kristopher
Vice President, Head of Legal
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-24+87,500→ 87,500 totalExercise: $1.13Exp: 2032-02-24→ Common Stock (87,500 underlying) - Award
Restricted Stock Unit
2022-02-24+18,750→ 18,750 total→ Common Stock (18,750 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit is the economic equivalent of one share of PhaseBio Pharmaceuticals, Inc. common stock and is converted into common stock upon vesting subject to the reporting person's continued service through each such date.
- [F2]These Restricted Stock Units vest in equal one-third amounts on April 1, 2023, 2024, and 2025.
- [F3]The shares subject to the option shall vest in equal monthly installments over 48 months from February 24, 2022, subject to the reporting person's continued service through each such date.